Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers

BACKGROUND: There has been an increase in 'risk sharing' schemes for pharmaceuticals between healthcare institutions and pharmaceutical companies in Europe in recent years as an additional approach to provide continued comprehensive and equitable healthcare. There is though confusion surro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Adamski, Jakub, Godman, Brian, Ofierska-Sujkowska, Gabriella, Osińska, Bogusława, Herholz, Harald, Wendykowska, Kamila, Laius, Ott, Jan, Saira, Sermet, Catherine, Zara, Corrine, Kalaba, Marija, Gustafsson, Roland, Garuolienè, Kristina, Haycox, Alan, Garattini, Silvio, Gustafsson, Lars L
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Correspondence
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2906457/
https://ncbi.nlm.nih.gov/pubmed/20529296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6963-10-153
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados